Pharmaniaga Bhd (7081)
Bursa Malaysia · Malaysia · prices in MYR · close of 27 Oct 2026
Key indicators
| Last close | MYR 0.790 |
|---|---|
| 52-week range | 0.770 – 1.700 |
| Return, 1 month / 3 months | −26.2% / −31.6% |
| Return, 1 year / 3 years | −37.2% / −34.3% |
| Trend | Below its 200-day average |
| RSI (14) | 23 |
| Volatility (1 year) | 46.8% |
| Worst drawdown (1 year) | -51.7% |
| Average daily value traded | 2.59M MYR |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Pharmaniaga is a Malaysian pharmaceutical company based in the country, engaged in manufacturing and distributing medicines and healthcare products. It produces generic pharmaceuticals and other pharmaceutical preparations at its own facilities and supplies them through distribution operations to hospitals, clinics, pharmacies and other healthcare customers, including public sector health services and private healthcare providers. Its business spans the making of pharmaceutical products and the logistics of delivering them across Malaysia, serving both government-linked and commercial healthcare markets.
The shares are listed on the Bursa Malaysia in Malaysia under the code 7081, and the price on this page is in Malaysian ringgit (MYR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Pharmaniaga Bhd (7081) trades on the Bursa Malaysia in Malaysia. It last closed at MYR 0.790 on 27 October 2026.
Its price-based Market X-Ray is 27 out of 100 (a weak price profile), ranking 908 of 1,066 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 37.2% and over the last three months it fell 31.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Bursa Malaysia
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 7 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -35.1% | ||
| From 52-week high | -51.4% | ||
| Momentum | 15 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -31.6% | ||
| 6-month return | -34.7% | ||
| 12-month return, skipping the last month | -15.0% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 46.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -51.7% | ||
| Liquidity | 85 · Strong | Trades actively. | |
| Average daily value traded | 2.59M MYR | ||
| Zero-volume days | 1.7% | ||
| Income | 15 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | −26.2% |
| 3 months | −31.6% |
| 6 months | −34.7% |
| 1 year | −37.2% |
| 3 years | −34.3% |
| 5 years | −62.8% |
Signals
| 50-day / 200-day average | 1.032 / 1.217 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.034 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | MYR 0.0048 |
| 5 Jun 2026 | MYR 0.0025 |
| 8 Dec 2022 | MYR 0.0060 |
| 9 Sep 2022 | MYR 0.0050 |
| 7 Jun 2022 | MYR 0.0080 |
| 7 Mar 2022 | MYR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Bursa Malaysia; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.